| 摘要 |
<p>The present invention relates to novel proteins and to their production, from the prostase family. In particular, the invention relates to a genetically modified prostase wherein the protein is mutated in its active site. Such antigens may be formulated to provide vaccines for the treatment of prostate tumours. Methods for purifying prostase protein and homologues are also provided.</p> |
